Association between clinical and laboratory factors and response to sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a retrospective observational study-Reference-Cited by-同舟云学术

Association between clinical and laboratory factors and response to sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes: a retrospective observational study

Published:2024-05-23 Issue:8 Volume:25 Page:1095-1104
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Pitsiava Sofia¹,Dimakopoulos Georgios²,Tsimihodimos Vasilis³,Kotsa Kalliopi⁴,Koufakis Theocharis⁵^ORCID

Affiliation:

1. School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

2. BIOSTATS, Epirus Science and Technology Park Campus of the University of Ioannina, Ioannina, Greece

3. Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece

4. Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

5. Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2364054

Reference45 articles.

1. Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review

2. Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United States

3. SGLT inhibitors on weight and body mass: A meta‐analysis of 116 randomized‐controlled trials

4. Sodium-glucose cotransporter inhibitors: beyond glycaemic control

5. An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors